Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cocrystal Pharma, Inc. - Common Stock
(NQ:
COCP
)
2.480
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.480
Bid (Size)
2.560 (5)
Ask (Size)
3.100 (1)
Prev. Close
2.480
Today's Range
2.480 - 2.480
52wk Range
1.325 - 3.100
Shares Outstanding
10,173,790
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 05, 2024
Via
Benzinga
Performance
YTD
+41.09%
+41.09%
1 Month
+16.98%
+16.98%
3 Month
+45.03%
+45.03%
6 Month
-2.75%
-2.75%
1 Year
+40.91%
+40.91%
More News
Read More
Toll Brothers To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
August 22, 2024
Via
Benzinga
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
August 15, 2024
Via
ACCESSWIRE
Recap: Cocrystal Pharma Q4 Earnings
March 28, 2024
Via
Benzinga
Recap: Cocrystal Pharma Q3 Earnings
November 13, 2023
Via
Benzinga
Analyst Ratings for Cocrystal Pharma
August 15, 2023
Via
Benzinga
Why Cocrystal Pharma Shares Are Trading Higher Today
April 10, 2023
Via
Benzinga
COCP Stock Earnings: Cocrystal Pharma Misses EPS for Q2 2024
August 14, 2024
Via
InvestorPlace
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024
May 13, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 10, 2024
Via
Benzinga
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023
March 28, 2024
Via
InvestorPlace
Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap
March 05, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
November 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 15, 2023
Via
Benzinga
$2M Bet On Cocrystal Pharma? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
April 10, 2023
Via
Benzinga
Why Pioneer Natural Resources Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
April 10, 2023
Via
Benzinga
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 07, 2023
Via
Benzinga
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
January 25, 2023
Via
Benzinga
Cocrystal Pharma Discusses Clinical Progress and Significance of Its Novel Antiviral Therapeutics Pipeline with The Stock Day Podcast
January 23, 2023
Via
Newsfile
Exposures
COVID-19
Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022
December 01, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
Cocrystal Pharma Posts Favorable Safety Data From Oral Antiviral Against Influenza A
November 17, 2022
Via
Benzinga
Cocrystal Pharma Announces Favorable Safety Data from the Phase 1 Study with Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A
November 17, 2022
From
Cocrystal Pharma, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.